Secukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment

Main Article Content

PCM van de Kerkhof
K Reich
CL Leonardi
A Blauvelt
NN Mehta
TF Tsai
R You
P Papanastasiou
M Milutinovic
CEM Griffiths


psoriasis, secukinumab, clinical trial


Abstract not available.


Disclosures: Study sponsored by Novartis.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 4 > >>